(以下内容从西南证券《医药行业创新药周报:2025年8月第四周创新药周报》研报附件原文摘录)A股和港股创新药板块及XBI指数本周走势2025年8月第四周,陆港两地创新药板块共计27个股上涨,81个股下跌。其中涨幅前三为艾力斯(25.62%)、迈威生物-U(22.39%)、荣昌生物(21.02%)。跌幅前三为欧康维视(-21.29%)、药明巨诺-B(-17.91%)、创胜集团-B(-16.75%)。...
Source Link(以下内容从西南证券《医药行业创新药周报:2025年8月第四周创新药周报》研报附件原文摘录)A股和港股创新药板块及XBI指数本周走势2025年8月第四周,陆港两地创新药板块共计27个股上涨,81个股下跌。其中涨幅前三为艾力斯(25.62%)、迈威生物-U(22.39%)、荣昌生物(21.02%)。跌幅前三为欧康维视(-21.29%)、药明巨诺-B(-17.91%)、创胜集团-B(-16.75%)。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.